Page last updated: 2024-10-30

metformin and Icterus

metformin has been researched along with Icterus in 3 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hieronimus, A1
Klein, R1
Häring, HU1
Fritsche, A1
Wagner, R1
Lin, KD1
Lin, JD1
Juang, JH1
Streda, M1

Reviews

1 review available for metformin and Icterus

ArticleYear
Glucose tolerance tests in the clinical picture of chronic liver diseases.
    Acta Universitatis Carolinae. Medica. Monographia, 1975, Issue:67

    Topics: Adolescent; Adult; Age Factors; Aged; Alanine Transaminase; Aspartate Aminotransferases; Body Weight

1975

Other Studies

2 other studies available for metformin and Icterus

ArticleYear
Jaundice from diabetes therapy.
    Diabetes care, 2014, Volume: 37, Issue:3

    Topics: Adult; Diabetes Mellitus; Diagnosis, Differential; Follow-Up Studies; Humans; Hypoglycemic Agents; J

2014
Metformin-induced hemolysis with jaundice.
    The New England journal of medicine, 1998, Dec-17, Volume: 339, Issue:25

    Topics: Hemolysis; Humans; Hyperbilirubinemia; Hypoglycemic Agents; Jaundice; Male; Metformin; Middle Aged

1998